Yuyu Pharma Inc (000225) - Total Liabilities

Latest as of March 2026: ₩64.72 Billion KRW ≈ $43.86 Million USD

Based on the latest financial reports, Yuyu Pharma Inc (000225) has total liabilities worth ₩64.72 Billion KRW (≈ $43.86 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore investment intensity of Yuyu Pharma Inc to see how much of total assets are deployed in long-term investments.

Yuyu Pharma Inc - Total Liabilities Trend (2014–2025)

This chart illustrates how Yuyu Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Yuyu Pharma Inc asset portfolio.

Yuyu Pharma Inc Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Physitrack PLC ST:PTRK	Sweden	Skr8.71 Million
DistIT AB (publ) ST:DIST	Sweden	Skr394.40 Million
Medifron DBT Co. Ltd KQ:065650	Korea	₩86.61 Billion
Mixed Martial Arts Group Limited NYSE MKT:MMA	USA	$5.35 Million
Ugint Co Ltd KQ:195990	Korea	₩22.30 Billion
Samil Co.Ltd KQ:032280	Korea	₩41.68 Billion
Sunlands Technology Group NYSE:STG	USA	$1.10 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Yuyu Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Yuyu Pharma Inc (000225) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma Inc (2014–2025)

The table below shows the annual total liabilities of Yuyu Pharma Inc from 2014 to 2025.

Year	Total Liabilities	Change
2025-12-31	₩66.68 Billion ≈ $45.19 Million	-8.19%
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	--

About Yuyu Pharma Inc

KO:000225 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$14.43 Million

₩21.30 Billion KRW

Market Cap Rank

#26186 Global

#1973 in Korea

Share Price

₩3635.00

Change (1 day)

-1.76%

52-Week Range

₩3375.00 - ₩5250.00

All Time High

₩25149.31